Dr. David Toub, Senior Vice President of Medical Affairs at Gynesonics was featured on an episode of the HealthiHer podcast with host Dr. Amy Brenner. Tune in to this enlightening discussion as Dr. Brenner and Dr. Toub navigate the landscape of fibroid treatment, offering valuable insights into the
UConn Health Is the First and Only in Connecticut to Offer Innovative New Procedure to Treat Uterine Fibroids
UConn Health is the first in Connecticut to offer Sonata® treatment for uterine fibroids, providing a non-surgical, incisionless option using radiofrequency ablation. This procedure significantly reduces fibroid symptoms such as heavy and painful menstruation. Patient Jaime Sanchez, who underwent
Bon Secours Educates Women on Fibroid Awareness Month
In recognition of Fibroid Awareness Month, Dr. Edward Heidtman from Bon Secours recently shared insights on WSPA 7NEWS regarding advanced treatment options for fibroids and the importance of empowering women to take control of their health. His interview provides great information on managing
Incisionless fibroid treatment option now available in West Virginia
Stephen Bush, MD; Todd DePond, MD; Karinna Andrews, DO and Emily Montgomery, MD, with CAMC Obstetrics and Gynecology at Women and Children’s Hospital, are the only Ob-Gyn’s in West Virginia offering the Sonata® Treatment for women suffering from debilitating symptoms caused by uterine
New, Incision-free Treatment Option for Uterine Fibroids Now Available at UP Health System – Portage
UP Health System – Portage is the first facility in Michigan's Upper Peninsula to offer Sonata Treatment for women with fibroids! This minimally invasive treatment offers relief from fibroids while preserving the uterus. Dr. Evon Schexnaydre, a recent addition to UPHS's OB/GYN team, calls Sonata "a
Sonata Treatment and the Future of FemTech
Maneesha Ghiya of FemHealth Ventures talks with CNBC's Women & Wealth to discuss the optimistic future of FemTech. Ghiya shares how nearly dying from complications after childbirth prompted her to create FemHealth Ventures to be a vehicle for funding better diagnostics, research, and treatments
Minimally Invasive Sonata Treatment for Uterine Fibroids Now Offered in Kentucky
Women in the Kentucky area now have an innovative solution for managing heavy periods caused by symptomatic uterine fibroids. Dr. Mark Hoffman and the University of Kentucky have embraced the Sonata Treatment, joining a growing community of physicians offering this minimally invasive alternative to
Gynesonics to announce completion of latest funding round soon, new CEO says
Originally published by Mergermarket 25 Oct 2023 17:55 EDT Gynesonics, a Redwood City, California-based women’s healthcare and medical device company, plans to announce the completion of a significant financing round soon, said new CEO Skip Baldino. The company announced a USD 25m financing